To determine the plausibility of these drugs in BCa cells, we examined the expression of STAT3 in BCa cells and found that all the cell line models expressed STAT3 and p-STAT3, thus allowing us to assess the anti-tumor effects of STAT3 inhibitors. The gene discussed is STAT3; the disease is neoplasm.